A Study of Aezea® (Cenersen) in Transfusion Dependent Anemia Associated With Myelodysplastic Syndrome (MDS)
Clinical trial NCT02243124 · TERMINATED
Trial details
- NCT number
- NCT02243124
- Sponsor
- Eleos, Inc.
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2014-09-01
- Primary completion
- 2015-09-30
- Enrollment
- 9
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.